Prostate Cancer
Statin users receiving androgen ablative therapies had a 35% reduced risk of death from advanced prostate cancer.
Prostate Cancer
Regardless of statin use, screening was associated with a lower incidence of metastatic tumors.
Prostate Cancer
Strong inverse association found for PTEN-null cancer but not for PTEN-intact cancers.
Prostate Cancer
Patients who were diagnosed early on in the study, or who received endocrine therapy or radical prostatectomy, exhibited a lower HR for mortality vs other patients with PC.
Prostate Cancer
Stronger effect on prostate cancer-linked, all-cause mortality for those with prediagnostic use.
General Oncology
Cancer patients reported concerns about the risks that COVID-19 poses to themselves and their family, how delayed care might affect their outcomes, and the social and economic impacts of the pandemic.
Prostate Cancer
In a study, statin use was associated with a 36% decreased risk for death among men initiating androgen deprivation therapy for recurrent prostate cancer following primary or salvage radiation therapy.
General Oncology
If the current COVID-19 trends persist, the NCI estimates that the pandemic’s impact could threaten the trend of annually decreasing cancer mortality seen in the US since 1990.
Prostate Cancer
There are up to 80 ADCs in clinical development with close to 600 ongoing trials.
Uncategorized
A study looking at the effect of genetic variations on the pharmacologic activity of metformin found that use of the drug was associated with an increased risk of prostate cancer overall and of high-grade prostate cancer.